Potential role of Th17 cells in the pathogenesis of adult-onset Still's disease

IL-23 Promotes Maintenance but Not Commitment to the Th17 Lineage

(2014) G. L. Stritesky et al.   JOURNAL OF IMMUNOLOGY

LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study

(2010) M. C. Genovese et al.   ARTHRITIS AND RHEUMATISM

Plasma IL-17A Is Increased in New-Onset SLE Patients and Associated with Disease Activity

(2010) Xiao Qi Chen et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Cutting Edge: Mast Cells Express IL-17A in Rheumatoid Arthritis Synovium

(2010) A. J. Hueber et al.   JOURNAL OF IMMUNOLOGY

Th17 and natural Treg cell population dynamics in systemic lupus erythematosus

(2009) Ji Yang et al.   ARTHRITIS AND RHEUMATISM

Suppression of Experimental Autoimmune Uveoretinitis by Anti-IL-17 Antibody

(2009) Rui Zhang et al.   CURRENT EYE RESEARCH

Interleukin-17 as a drug target in human disease

(2009) Stefan Ivanov et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Crucial role of the interleukin-6/interleukin-17 cytokine axis in the induction of arthritis by glucose-6-phosphate isomerase

(2008) Keiichi Iwanami et al.   ARTHRITIS AND RHEUMATISM

Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: Implications for Th17-mediated inflammation in auto-immunity

(2008) Chun Kwok Wong et al.   CLINICAL IMMUNOLOGY